A University of Illinois and Mayo collaboration has demonstrated a novel gene expression analysis technique that can accurately measure levels of RNA quickly and directly from a cancerous tissue ...

Prostate cancer patients who do not respond well to PSMA-targeted therapy often have potentially treatable mutations in their DNA damage-repair genes, according to research published in the May issue ...

Molecular biomarkers can serve as useful diagnostic markers, as prognostic markers for predicting clinical behavior, or as targets for new therapeutic strategies. Application of expression microarray ...

Activation of the androgen receptor (AR) despite androgen ablation and anti-androgen therapy seems to play a pivotal role in hormone-refractory progression of prostate cancer. The above postulation is ...

A University of Illinois and Mayo collaboration has demonstrated a novel gene expression analysis technique that can accurately measure levels of RNA quickly and directly from a cancerous tissue ...

Data suggest that circulating 25-hydroxyvitamin D [25(OH)D] interacts with the vitamin D receptor (VDR) to decrease proliferation and increase apoptosis for some malignancies, although evidence for ...

The University Hospitals Urology Institute is the first health care facility in Northeast Ohio to use a new technique to diagnose prostate cancer, officials recently announced. According to UH, the ...

In 2014, prostate cancer was the leading cause of newly diagnosed cancers in men and the second leading cause of cancer death in men. A team of scientists and physicians now describe a novel imaging ...

Scientists at the Karolinska Institute in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnosis and thereby improve prostate cancer screening. Now, the same team ...

Earlier this week, researchers presented data from the OPTIMUM (Optimization of Prostate Biopsy – Micro-Ultrasound Versus MRI) trial at the European Association of Urology Congress in Madrid, Spain.